Previous studies have suggested that higher levels of Ki-67 in patients with early-stage breast cancer are associated with a worse prognosis and can accurately determine whether breast cancer has metastasised, thus providing a valuable reference for clinical diagnosis and treatment [26, 27]. Here, MKI67 is linked to breast cancer.